XML 20 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
12 Months Ended
Dec. 31, 2012
Segment Reporting [Abstract]  
Revenues by Product
Product revenues, net consisted of the following:
 
2012
 
2011
 
2010
 
(in thousands)
    INCIVEK
$
1,161,813

 
$
950,889

 
$

    KALYDECO
171,645

 

 

      Total product revenues, net
$
1,333,458

 
$
950,889

 
$

Revenues and Property and Equipment by Location
The following table summarizes total revenues from external customers and collaborators by geographic region. Product revenues are attributed to countries based on the location of the customer. Collaborative revenues are attributed to the operations of the Company in the United States. Royalty revenues are attributed to countries based on the location of the collaborator.
 
2012
 
2011
 
2010
 
(in thousands)
United States
$
1,373,516

 
$
1,389,568

 
$
143,370

Outside of the United States
 
 
 
 
 
Europe
129,786

 
20,289

 

Other
23,740

 
769

 

Total revenues outside of the United States
153,526

 
21,058

 

Total revenues
$
1,527,042

 
$
1,410,626

 
$
143,370

The following table summarizes property and equipment, net by location:
 
As of December 31,
 
2012
 
2011
 
(in thousands)
United States
$
400,102

 
$
109,480

Outside of the United States
 
 
 
United Kingdom
30,622

 
21,377

Other
2,885

 
2,319

Total property and equipment, net outside of the United States
33,507

 
23,696

      Total property and equipment, net
$
433,609

 
$
133,176

Significant Customers
The following table summarizes gross revenues and accounts receivable from each of the Company’s customers who individually accounted for 10% or more of total gross revenues and/or 10% or more of total accounts receivable:
 
Percent of Total Gross Revenues
Percent of Accounts Receivable
 
Year Ended December 31,
As of December 31,
 
2012
 
2011
 
2010
2012
2011
AmerisourceBergen Drug Corporation
32
%
 
25
%
 
%
22
%
35
%
McKesson Corporation
29
%
 
24
%
 
%
26
%
30
%
Cardinal Health Incorporated
15
%
 
15
%
 
%
<10
%
20
%
Janssen
<10
%
 
19
%
 
21
%
26
%
10
%
Mitsubishi Tanabe
<10
%
 
<10
%
 
57
%
%
<10
%